This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP
page 1 of 5
Please click on Next tab to advance through activity.
Tell us what you think about Healio.com »
Get the latest news and education delivered to your inbox
©2019 Healio All Rights Reserved.
Terms of Credit
Release Date: 1/7/2019
Expiration Date: 1/6/2020
Estimated Time to Complete
Identifying and treating patients with Chronic Obstructive Pulmonary Disease (COPD) is urgent in light of the mortality, morbidity and economic consequences of the disease. CAPTURING COPD: A Team Approach to Diagnosis, Treatment and Management is a free CME/CNE activity consisting of nine 15-20 minute lessons disbursed across four main modules. These include an overview of the disease, how to effectively diagnose patients, best care practices and therapies for treating patients, and methods to ensure patient adherence. The program features patient cases with learner interaction and is presented by experts in the field of COPD, including Barry Make, MD, Bruce Bender, PhD, and Deborah Fending, RN, BSN, AE-C of National Jewish Health, and Barbara Yawn, MD, of the University of Minnesota.
© 2019 National Jewish Health
This educational activity is supported by an independent educational grant from AstraZeneca Pharmaceuticals LP as a supplement to NIH grant 1R01HL136682-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of AstraZeneca, the NHLBI or the NIH.
Module 4: COPD Patient-Centered Care-Adherence with Therapy
It is designed for primary care physicians and community pulmonologists, nurse practitioners, physician assistants, and nurses who are involved in the management of COPD.
Bruce Bender, PhD
Professor of Pediatrics and Psychiatry Head, Division of Pediatric Behavioral Health
Co-Director, Center for Health Promotion
National Jewish Health, Denver, CO
Deborah Fending, RN, BSN, AE-C
Staff Development Nurse, Center for Health Promotion Department of Nursing
National Jewish Health, Denver, CO
Faculty/Planner/Reviewer Disclosure/Conflict of Interest Policy
In accordance with the Accreditation Council for Continuing Medical Education, National Jewish Health requires that all program faculty, content developers, CME approval committee, and those in position to control the content of this activity disclose any significant financial interest or other relationship with any proprietary entity producing health care goods or services, with the exemption of non-profit or governmental organizations and non-health care related companies. Our goal is to ensure that there is no compromise of the ethical relationship that exists between those in a position to control the content of the activity and those attending the activity and their respective professional duties.
All CME educational activities sponsored by National Jewish Health are reviewed by our faculty CME committee to ensure a balanced and evidence-based presentation. Any potential conflict of interest among program faculty has been identified and resolved according to ACCME guidelines.
Bruce Bender, PhD: Consultant for KAC Health and an Advisory Board Member for GlaxoSmithKline and Propeller Health
Deborah Fending, RN, BSN, AE-C: Advisory Board Member for Boehringer Ingelheim
Harold Nelson, MD: Consultant and Speaker for ALK and on a Data Safety Monitoring Board for Pearl Therapeutics
Ann Mullen, RN, CNS, MSB, AE-C, CD, TTS: Has no financial interests/relationships or affiliations in relation to this activity
Allidah Hicks, RN, MS, AE-C: Has no financial interests/relationships or affiliations in relation to this activity
Tristan Huie, MD: Investigator for Boehringer Ingelheim and the Pulmonary Fibrosis Foundation
Andrea Harshman, MHA, CHCP, CMP-HC: No financial interests/relationships or affiliations in relation to this activity
Stephanie Corder, ND, RN, CHCP: No financial interests/relationships or affiliations in relation to this activity
Matthew Stern, MS: No financial interests/relationships or affiliations in relation to this activity
Lauren Rieck: No financial interests/relationships or affiliations in relation to this activity
Randall Brown, MD: Speaker for AstraZeneca, Circassia, Integrity CE, One City Health, Sunovion, and Teva. He is a consultant for One City Health and serves on the advisory boards for AstraZeneca, One City Health, and Sanofi/Genzyme. He also has a relationship with the Allergy and Asthma Network
Lyle Fanagan, MD: No financial interests/relationships or affiliations in relation to this activity
Daniel Howard, MD: No financial interests/relationships or affiliations in relation to this activity
Lyndee Knox, MD: No financial interests/relationships or affiliations in relation to this activity
Elisha Malanga: No financial interests/relationships or affiliations in relation to this activity
Lindsay Shade, MHS, PA-C: Investigator for GlaxoSmithKline, IDx, LLC., Theracos Sub, LLC., and Novartis Pharmaceuticals. She also has a relationship with Johnson and Johnson
Byron Thomashow, MD: Advisory boards for AstraZeneca and GlaxoSmithKline and a consultant for Boehringer Ingelheim
National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Credit Designation Statement
Physicians – National Jewish Health designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™ for each program. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurses – Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 1.2 contact hours.
This Enduring Material activity, Capturing COPD: A Team Approach to Diagnosis, Treatment and Management, has been reviewed and is acceptable for credit by the American Academy of Family Physicians. Term of approval begins 10/05/2018. Term of approval is for one year from this date. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Approved for 1.0 AAFP Prescribed credits.
PAs may claim a maximum of 1.0 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit™ from organizations accredited by ACCME or recognized state medical society.
The American Academy of Nurse Practitioners Certification Board (AANPCB) accepts AMA PRA Category 1 Credit™ from organizations accredited by the ACCME. Individuals are responsible for checking with AANPCB for further guidelines.
Requirements for Successful Completion
In order to receive credit, participants must complete the pre-test, view the activity and complete the post-test and evaluation form. There are no pre-requisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon successful completion of the post-test with a passing score of ≥ 75%, and evaluation form.
National Jewish Health (“NJH”) and its officers, Board of Directors, faculty, employees, representatives, and other agents (collectively, “NJH Parties”) shall not be responsible in any capacity for, and do not warrant any content whatsoever, in any NJH publication or other product (in any medium), or the use or reliance on any such content, and expressly disclaim any and all liability for such content. All such responsibility for content and use of product solely rests with the authors or the advertisers, as the case may be.
By way of example, without limiting the foregoing, this disclaimer of liability applies to the accuracy, completeness, effectiveness, quality, appearance, ideas, or products, as the case may be, of or resulting from, any statements, references, articles, positions, claimed diagnosis, claimed possible treatments, services, or advertising, express or implied, contained in any NJH live meeting, publication, online course or other product.
Furthermore, the content should not be considered medical advice and is not intended to replace consultation with a qualified medical professional. Under no circumstances, including negligence, shall any of the NJH Parties be liable for any DIRECT, INDIRECT, INCIDENTAL, SPECIAL or CONSEQUENTIAL DAMAGES, or LOST PROFITS that result from any of the foregoing, regardless of legal theory and whether or not claimant was advised of the possibility of such damages.
Disclosure of Unlabeled Use
The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use. No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports. Please refer to the official prescribing information for each product for discussion of approved indicators, contraindications and warnings.